Skip to main content
Fig. 3 | Clinical Proteomics

Fig. 3

From: Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma

Fig. 3

ROC curve analysis of autoantibodies against PRDX2 and PRDX3 for NPC diagnosis. a ROC curve for serum autoantibodies against PRDX2 and PRDX3 and their combination for patients with NPC versus normal controls. b ROC curve for serum autoantibodies against PRDX2 and PRDX3 and their combination for patients with early NPC versus normal controls. ROC receiver operating characteristic

Back to article page

Clinical Proteomics

ISSN: 1559-0275